ICH is a unique global forum that brings together regulatory authorities and the pharmaceutical industry to discuss the scientific and technical aspects of pharmaceutical development.
ICH produces harmonised technical guidelines to support standards for the development and registration of safe, effective and high-quality medicines around the world.
Founded 35 years ago and registered as a non-profit association under Swiss law in 2015, ICH has 25 members, 43 observers and a network of nearly 700 experts globally.
Learn how ICH has evolved over 35 years! ICH harmonised guidelines help to ensure that medicines are developed, tested and manufactured to meet consistent global standards that support patient safety, pharmaceutical product quality and efficacy.
ICH guidelines provide internationally harmonised recommendations for the development, registration and lifecycle management of medicines. Discover guidance that supports high-quality, safe and effective medicines, and efficient regulatory processes worldwide.
Public consultations are an essential part of the ICH guideline development process, providing stakeholders with the opportunity to review and comment on draft documents. Explore current consultations and contribute your expertise to help shape internationally harmonised guidelines.